|Day Low/High||7.41 / 7.88|
|52 Wk Low/High||6.07 / 23.97|
U.S. stock futures decline as Wall Street awaits another round of third-quarter earnings reports and global stocks trade mixed as investors monitored Brexit developments; Netflix, IBM and Bank of America report earnings Wednesday; McKesson, AmerisourceBergen and Cardinal Health reportedly are in talks to pay $18 billion to settle thousands of opioid-related lawsuits.
Jim Cramer says the market is happy to hear about a possible trade agreement, but without details, it's hard to maintain momentum. Here's your game plan for next week.
NEW YORK, Oct. 13, 2019 /PRNewswire/ -- Allegiant Travel Company (ALGT) Lifshitz & Miller announces investigation into possible securities laws in connection with a CBS News 60 Minutes segment criticizing Allegiant's safety and maintenance records.
Jim Cramer takes a look at Teradyne, MGM Resorts, Boot Barn, and Teva Pharmaceuticals.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will issue a press release on its third quarter 2019 financial results on Thursday, November 7, 2019 at 7:00 a.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that new AUSTEDO ® (deutetrabenazine) data will be presented at the 32 nd annual Psych Congress, October 3-6, 2019 in San Diego, California.
Teva Pharmaceutical Industries (NYSE and TASE: TEVA) announced today the retirement of Dr.
The Wall Street Journal reports the companies are considering participating in the bankruptcy proceedings of Purdue Pharma.
So many companies -- like Netflix, Facebook and Johnson & Johnson -- are not trading on earnings per share, but on factors that are nearly impossible to quantify.
Alder Biopharmaceuticals surges after rival Danish drugmaker Lundbeck announces plans to acquire the company and its late-stage migraine drug eptinezumab in a deal worth up to $1.95 billion.
HERZLIYA, Israel, Sept. 13, 2019 /PRNewswire/ -- InterCure (TASE: INCR), announced that subsidiary Canndoc has entered into a strategic distribution agreement with Salomon, Levin, Elstein (S.
Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced that the U.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the Company will present more than 30 analyses on fremanezumab, at the 19 th Congress of the International Headache Society (IHC), taking place in Dublin, Ireland on September 5-8,...
No company is safe from the litigation risk tied to the drug epidemic, but Johnson & Johnson may be one of the few guaranteed to survive.
Wall Street expects the healthcare giant can take the jolt from the penalty delivered by an Oklahoma judge in the state's opioid case against J&J.
U.S. stock futures rise modestly on Tuesday as investors are cautiously optimistic a trade deal between Washington and Beijing can be reached; Johnson & Johnson is found responsible for helping fuel the opioid crisis in Oklahome and is ordered to pay $572 million; Russian conglomerate Rostec confirms it filed a lawsuit in the United States to cancel its order for Boeing 737 MAX jets, a report says.
Jim Cramer takes a look at Union Pacific, Pfizer, Merck, AbbVie, Teva Pharmaceuticals, ABM Industries, Schlumberger and more.
Antares Pharma and Encana are on our radar today.
Teva says patients taking Ajovy experienced a significant reduction in migraine days compared to those receiving placebos.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that results from the Phase IIIb FOCUS study, which examined fremanezumab versus placebo in adult migraine patients who previously experienced inadequate responses to two to four...
Endo's stock price surges after the company announces a settlement with Cuyahoga and Summit counties, removing the company from a potentially damaging trial in state court in October.
NEW YORK, Aug. 20, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Teva Pharmaceutical Industries Ltd.
There has been an EpiPen shortage in the U.S., Europe and Canada, thanks to manufacturing delays at Pfizer.
Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced availability of the FDA-approved generic version of EpiPen Jr® 1 (epinephrine injection, USP) Auto-Injector, 0.
Allergan is said to be discussing paying $5 million while Endo is close to an agreement to pay $10 million, according to a report.
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C.
It's a process that involves harvesting gains by repeatedly writing call options against stocks steadily in decline.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.